AU6708096A - Propofol nanodispersions - Google Patents

Propofol nanodispersions

Info

Publication number
AU6708096A
AU6708096A AU67080/96A AU6708096A AU6708096A AU 6708096 A AU6708096 A AU 6708096A AU 67080/96 A AU67080/96 A AU 67080/96A AU 6708096 A AU6708096 A AU 6708096A AU 6708096 A AU6708096 A AU 6708096A
Authority
AU
Australia
Prior art keywords
nanodispersions
propofol
propofol nanodispersions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67080/96A
Inventor
Hans Georg Weder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vesifact AG
Original Assignee
Vesifact AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vesifact AG filed Critical Vesifact AG
Publication of AU6708096A publication Critical patent/AU6708096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67080/96A 1995-09-18 1996-08-29 Propofol nanodispersions Abandoned AU6708096A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH262095 1995-09-18
CH2620/95 1995-09-18
CH325795 1995-11-17
CH3257/95 1995-11-17
PCT/IB1996/000868 WO1997010814A1 (en) 1995-09-18 1996-08-29 Propofol nanodispersions

Publications (1)

Publication Number Publication Date
AU6708096A true AU6708096A (en) 1997-04-09

Family

ID=25690961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67080/96A Abandoned AU6708096A (en) 1995-09-18 1996-08-29 Propofol nanodispersions

Country Status (2)

Country Link
AU (1) AU6708096A (en)
WO (1) WO1997010814A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692322A5 (en) * 1997-05-26 2002-05-15 Westy Ag clear injectable formulation of propofol.
DE69936911T2 (en) 1998-02-10 2008-05-15 Sicor Inc., Irvine PROPOL-CONTAINING MEDICAMENT CONTAINING SULPHITE
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6623765B1 (en) 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US20040081670A1 (en) * 2001-02-11 2004-04-29 Dariush Behnam Method for producing an active ingredient concentrate, and an active ingredient concentrate
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
WO2004010941A2 (en) 2002-07-29 2004-02-05 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
WO2015155703A2 (en) * 2014-04-09 2015-10-15 Nanoceutica Laboratories Pvt. Ltd Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE4132677C2 (en) * 1991-10-01 1995-08-24 Braun Melsungen Ag Liposomes containing volatile inhalation anesthetics, their preparation and use
MY112798A (en) * 1994-02-04 2001-09-29 Karlshamns Lipidteknik Ab Oil-in-water emulsions
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations

Also Published As

Publication number Publication date
WO1997010814A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU6304196A (en) Substituted cyanophenyluracils
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5055996A (en) Switched-inverter modulator
AU5147496A (en) Fucopeptides
AU6708096A (en) Propofol nanodispersions
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5500196A (en) Anti-transpirants
AU6304396A (en) Substituted carbonylaminophenyluracils
AU5108596A (en) Morphine-3-esters
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6366496A (en) Document
AU6658696A (en) Substituted phenyluracils
AU5323096A (en) Substituted 6-azacholesten-3-ones
AU5878096A (en) Fasciotome
AU2609095A (en) Compartmentalizer
AU2161897A (en) Helicopter-airplane